HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.

Abstract
A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg.), norfloxacin (800 mg.) or ciprofloxacin (500 mg.). Cure was achieved in 163 of the 174 acute episodes (94%). More specifically, the cure rates were 97% (57 of 59 infections) with ofloxacin, 96.5% (56 of 58) with ciprofloxacin and 88% (50 of 57) with norfloxacin. While the initial cure rate of the acute urinary tract infections was 96% (112 of 117) in the premenopausal group, it reached only 90% (51 of 57) in the postmenopausal group. The 17 urinary tract infections that followed the initial 2-tablet quinolone treatment were cured by either an additional single dose, 2-tablet treatment with a different quinolone in 6 cases, a 1-day treatment with other adequate antibacterials in 9 and a 7-day treatment in 2. The 2-tablet quinolone treatment proved to be an effective, easy and cost-effective treatment for acute urinary tract infections in premenopausal and postmenopausal women.
AuthorsA Pfau, T G Sacks
JournalThe Journal of urology (J Urol) Vol. 149 Issue 3 Pg. 532-4 (Mar 1993) ISSN: 0022-5347 [Print] United States
PMID8437256 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Ciprofloxacin
  • Ofloxacin
  • Norfloxacin
Topics
  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Ciprofloxacin (administration & dosage, therapeutic use)
  • Female
  • Gram-Negative Bacterial Infections (drug therapy, microbiology)
  • Humans
  • Menopause
  • Middle Aged
  • Norfloxacin (administration & dosage, therapeutic use)
  • Ofloxacin (administration & dosage, therapeutic use)
  • Prospective Studies
  • Urinary Tract Infections (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: